These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 4698286)

  • 1. Transaminations between amino acids and keto acids elevated in phenylketonuria and maple syrup urine disease.
    Lees GJ; Weiner N
    J Neurochem; 1973 Feb; 20(2):389-403. PubMed ID: 4698286
    [No Abstract]   [Full Text] [Related]  

  • 2. Further observations on the biochemical lesion in maple syrup urine disease.
    Dreyfus PM; Prensky AL
    Nature; 1967 Apr; 214(5085):276. PubMed ID: 6034241
    [No Abstract]   [Full Text] [Related]  

  • 3. Control of pyruvate and beta-hydroxybutyrate utilization in rat brain mitochondria and its relevance to phenylketonuria and maple syrup urine disease.
    Land JM; Mowbray J; Clark JB
    J Neurochem; 1976 Apr; 26(4):823-30. PubMed ID: 987160
    [No Abstract]   [Full Text] [Related]  

  • 4. [Biochemical investigations in ketoaminoaciduria].
    Lysiak W
    Acta Biol Med (Gdansk); 1972; 17(1):7-23. PubMed ID: 4664697
    [No Abstract]   [Full Text] [Related]  

  • 5. [Aminoacid metabolism disorders in infancy with special reference to phenylketonuria. II. Aminoacid metabolism and general physiopathology of aminoacidopathies].
    Segni G
    Minerva Nipiol; 1970; 20(4):83-110. PubMed ID: 4396023
    [No Abstract]   [Full Text] [Related]  

  • 6. [A case of maple syrup urine disease. Biochemical study].
    Lamedica GM; Fregonese B; Moroni G; Famularo L
    Minerva Pediatr; 1972 Dec; 24(43):2143-9. PubMed ID: 4652219
    [No Abstract]   [Full Text] [Related]  

  • 7. Classical maple syrup urine disease: cofactor resistance.
    Elsas LJ; Pask BA; Wheeler FB; Perl DP; Truster S
    Metabolism; 1972 Oct; 21(10):929-44. PubMed ID: 4342010
    [No Abstract]   [Full Text] [Related]  

  • 8. Lithium-induced changes in brain amino acids, alpha-ketoacids & transaminases.
    Khan SA; Siddiqui AQ; Siddiqui MA
    Indian J Med Res; 1984 Apr; 79():514-9. PubMed ID: 6490115
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of alpha-oxoglutarate and pyruvate oxidation by alpha-oxoderivatives of leucine and valine in rat tissues.
    Lysiak W; Stepiński J; Angielski S
    Acta Biochim Pol; 1970; 17(2):131-41. PubMed ID: 5530500
    [No Abstract]   [Full Text] [Related]  

  • 10. Large neutral amino acids auto exchange when infused by microdialysis into the rat brain: implication for maple syrup urine disease and phenylketonuria.
    Zielke HR; Zielke CL; Baab PJ; Collins RM
    Neurochem Int; 2002 Apr; 40(4):347-54. PubMed ID: 11792465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased essential amino acid requirements without catabolism in phenylketonuria and maple syrup urine disease.
    Ruch T; Kerr D
    Am J Clin Nutr; 1982 Feb; 35(2):217-28. PubMed ID: 7064884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Branched chain alpha-keto acid metabolism. I. Isolation, purification, and partial characterization of bovine liver alpha-ketoisocaproic:alpha-keto-beta-methylvaleric acid dehydrogenase.
    Connelly JL; Danner DJ; Bowden JA
    J Biol Chem; 1968 Mar; 243(6):1198-203. PubMed ID: 5689906
    [No Abstract]   [Full Text] [Related]  

  • 13. Synaptic plasma membrane Na(+), K (+)-ATPase activity is significantly reduced by the alpha-keto acids accumulating in maple syrup urine disease in rat cerebral cortex.
    Wajner A; Bürger C; Dutra-Filho CS; Wajner M; de Souza Wyse AT; Wannmacher CM
    Metab Brain Dis; 2007 Mar; 22(1):77-88. PubMed ID: 17295076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of acetylcholine synthesis and of carbohydrate utilization by maple-syrup-urine disease metabolites.
    Gibson GE; Blass JP
    J Neurochem; 1976 Jun; 26(6):1073-8. PubMed ID: 945329
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition, by 2-oxo acids that accumulate in maple-syrup-urine disease, of lactate, pyruvate, and 3-hydroxybutyrate transport across the blood-brain barrier.
    Cremer JE; Teal HM; Cunningham VJ
    J Neurochem; 1982 Sep; 39(3):674-7. PubMed ID: 7201506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The enzyme defect in maple syrup urine disease (branched chain ketoaciduria).
    Seegmiller JE; Westall RG
    J Ment Defic Res; 1967 Dec; 11(4):288-94. PubMed ID: 5582930
    [No Abstract]   [Full Text] [Related]  

  • 17. Mammalian alpha-keto acid dehydrogenase complexes. IV. Substrate specificities and kinetic properties of the pig heart pyruvate and 2-oxyoglutarate dehydrogenase complexes.
    Kanzaki T; Hayakawa T; Hamada M; Fukuyoshi Y; Koike M
    J Biol Chem; 1969 Mar; 244(5):1183-7. PubMed ID: 5812959
    [No Abstract]   [Full Text] [Related]  

  • 18. Enzymatic synthesis of O-alkylhomoserine.
    Murooka Y; Harada T
    Biochim Biophys Acta; 1969 Oct; 192(1):73-80. PubMed ID: 5347972
    [No Abstract]   [Full Text] [Related]  

  • 19. Chloride-dependent inhibition of vesicular glutamate uptake by alpha-keto acids accumulated in maple syrup urine disease.
    Reis M; Farage M; Wolosker H
    Biochim Biophys Acta; 2000 Jul; 1475(2):114-8. PubMed ID: 10832024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transamination of 5-aminolevulinic acid and its oxo-derivative 4,5-dioxovaleric acid in animal tissues].
    Spryshkova RA; Poznanskaia AA
    Vopr Med Khim; 1966; 12(5):473-6. PubMed ID: 6000169
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.